Abcam & rsquo;s new CRISPR-Cas9 cell lines for target identification, validation and pathway discovery & nbsp;

Abcam’s new CRISPR-Cas9 knockout (KO) cell lines provide reproducible, single gene KOs that support the interrogation of the relationship between genotype and phenotype. 

Source: The Scientist - February 5, 2020 Category: Science Tags: The Scientist The Marketplace Source Type: news